SCHEMBL11299083

SCHEMBL11299083

CC(C)c1ccc(N(c2ccc(C(=O)NO)cc2)C2CCNC2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 13/20 0.42
▸ HDAC1 Q13547 10/20 0.42
▸ HDAC8 Q9BY41 6/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ EGFR P00533 1/20 0.38
▸ ERBB2 P04626 1/20 0.38
▸ HDAC3 O15379 3/20 0.38
▸ HDAC2 Q92769 3/20 0.38
▸ PSEN1 P49768 1/20 0.37
▸ PSEN2 P49810 1/20 0.37
▸ APH1B Q8WW43 1/20 0.37
▸ NCSTN Q92542 1/20 0.37
▸ APH1A Q96BI3 1/20 0.37
▸ PSENEN Q9NZ42 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301397 0.89 HDAC1 (0.39) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11301754 0.87 PSEN1 (0.42) HDAC6HDAC1HDAC8HDAC2PSEN1
SCHEMBL11306357 0.85 ALDH1A1 (0.46) HDAC6HDAC1HDAC8SMN1; SMN2NPC1
SCHEMBL11305647 0.84 HDAC6 (0.41) HDAC6HDAC1HDAC8NPC1RAB9A
SCHEMBL11303328 0.84 HDAC8 (0.37) HDAC6HDAC1HDAC8RAB9APSEN1
SCHEMBL11297375 0.83 HDAC8 (0.44) HDAC6HDAC1HDAC8NPC1HDAC3
SCHEMBL11296595 0.83 HDAC6 (0.42) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11296107 0.83 HDAC8 (0.45) HDAC6HDAC1HDAC8RAB9AHDAC3
SCHEMBL11296049 0.82 HDAC6 (0.45) HDAC6HDAC1HDAC8NPC1RAB9A
SCHEMBL11304336 0.82 HDAC6 (0.42) HDAC6HDAC1HDAC8HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback